CORT
CORT
US2183521028
Corcept Therapeutics Incorporat
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 761.407.000 675.040.000
12.8%
Cost of Revenue 12.977.000 10.882.000
19.3%
Gross Profit 748.430.000 664.158.000
12.7%
703.633.000 527.207.000
33.5%
Operating Income 44.797.000 136.951.000
67.3%
Pretax Income 66.463.000 161.493.000
58.8%
Net Income Common Stockholders 98.171.000 139.733.000
29.7%
-- --
--
-- --
--
ende